Biologic Treatments of Psoriasis: An Update for the Clinician
Nicholas D Brownstone, Julie Hong, Megan Mosca, Edward Hadeler, Wilson Liao, Tina Bhutani, John Koo University of California, San Francisco, Department of Dermatology, Psoriasis and Skin Treatment Center, San Francisco, CA, USACorrespondence: Nicholas D BrownstoneUniversity of California, San Franci...
Guardado en:
Autores principales: | Brownstone ND, Hong J, Mosca M, Hadeler E, Liao W, Bhutani T, Koo J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d3701acd24e432b90c7f41db32b75cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges
por: el Hayderi L, et al.
Publicado: (2016) -
Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
por: Beck KM, et al.
Publicado: (2018) -
Search for genetic markers of predisposition to psoriasis and psoriatic arthritis
por: M. V. Smolnikova, et al.
Publicado: (2020) -
Targeting IL-23 in psoriasis: current perspectives
por: Fotiadou C, et al.
Publicado: (2018) -
Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
por: Machado Á, et al.
Publicado: (2018)